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High-Intensity Signals in Carotid Plaques
on T1-Weighted Magnetic Resonance Imaging Predict
Coronary Events in Patients With Coronary Artery Disease
Teruo Noguchi, MD,* Naoaki Yamada, MD,† Masahiro Higashi, MD,† Yoichi Goto, MD,*
Hiroaki Naito, MD†
Suita, Japan
Objectives The purpose of this study was to determine whether high-intensity carotid plaques visualized by a noncontrast
T1-weighted imaging technique, magnetization-prepared rapid acquisition with gradient echo (MPRAGE), predict
future coronary events in patients with clinically stable coronary artery disease (CAD).
Background Coronary plaque vulnerability to rupture can be assessed by examining for the presence of atherosclerosis and
measuring intima media thickness (IMT) in surrogate vessels such as the carotid arteries. We previously showed
that MPRAGE successfully identifies vulnerable carotid plaques as high-intensity signals. It remains unclear, how-
ever, if the presence of carotid high-intensity plaques (HIP) is associated with an increased risk of coronary
events.
Methods We examined the signal intensity of carotid plaques in 217 patients with clinically stable CAD using MPRAGE
with magnetic resonance imaging and measured IMT with ultrasonography. A carotid HIP was defined as a sig-
nal 200% that of the adjacent muscle. All patients were divided into 2 groups according to the presence or
absence of HIP, namely, the HIP group (n  116) and the non-HIP group (n  101), and were followed up for as
long as 72 months.
Results The presence of HIP was significantly associated with cardiac events compared to the non-HIP group (log-rank
p  0.0001). Furthermore, multivariate Cox regression analysis identified the presence of HIP as the strongest
independent predictor of cardiac events (hazard ratio: 3.15; 95% confidence interval: 1.93 to 5.58, p  0.0001)
compared with IMT (hazard ratio: 1.62, 95% confidence interval: 0.97 to 2.44, p  0.055) and other coronary
risk factors.
Conclusions Characterization of carotid plaques using magnetic resonance imaging with MPRAGE provides more clinically
relevant information for the risk assessment of CAD patients than IMT. (J Am Coll Cardiol 2011;58:416–22)
© 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.056Rupture of vulnerable atherosclerotic plaques in the
coronary vessels leads to acute coronary syndromes.
Collectively, recent studies suggest that, rather than
simply being a local vascular incident, plaque instability is
a systemic problem present in multiple vascular beds
throughout the body. Thus, it may be possible to assess
the vulnerability of coronary artery plaques to rupture and
the development of acute coronary syndromes by evalu-
ating the stability and composition of plaques in other
vessels (1–3). However, this has not been clearly estab-
From the *Department of Cardiovascular Medicine, National Cerebral and Cardio-
vascular Center, Suita, Japan; and the †Department of Radiology, National Cerebral
and Cardiovascular Center, Suita, Japan. The authors have reported that they have no
relationships to disclose.Manuscript received July 24, 2010; revised manuscript received January 6, 2011,
accepted January 31, 2011.lished, and prospectively identifying a high-risk coronary
artery disease (CAD) population vulnerable to plaque
rupture remains difficult.
See page 423
Magnetic resonance imaging (MRI) can be used to
noninvasively assess carotid plaque characteristics in vivo.
High-intensity signals observed in carotid plaques using
inversion recovery-based 3-dimensional T1-weighted imaging—
alternatively known as magnetization-prepared rapid acqui-
sition with gradient echo (MPRAGE) (4) or magnetic
resonance direct thrombus imaging (MRDTI) (5,6)—are
associated with recent ischemic cerebrovascular events
(6–8) and are related to complex plaques (type VI as
proposed by the American Heart Association) (9,10). Several
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July 19, 2011:416–22 Carotid Plaques on MR Predict Coronary Eventsgroups have used high-resolution multicontrast MRI to exam-
ine the relationship between plaque composition and cerebro-
vascular events, and their data suggest that MRI can success-
fully identify vulnerable carotid plaques (11–14). However, no
studies have evaluated the relationship between carotid artery
plaque vulnerability detected by MRI and subsequent coronary
events. In the present study, we hypothesized that the
presence of carotid high-intensity plaques (HIP) visualized by
MPRAGE predicted future coronary events in patients with
clinically stable CAD.
Methods
Patients. Between 2002 and 2005, 665 consecutive pa-
tients who underwent MRI with suspected or confirmed
atherosclerosis of the carotid artery at our institute were
considered for enrollment. The exclusion criteria for the
study were acute myocardial infarction (AMI), unstable
angina pectoris, severe valvular heart disease, end-stage
renal failure, cardiomyopathy, and infectious, chronic in-
flammatory, and autoimmune diseases. Among the 665
possible patients, 226 had a history of CAD described in
their medical records at our hospital. Stable CAD was
defined as the absence of episodes of angina at rest on
admission in patients with angiographically documented
stenosis 50% in at least 1 of the major coronary arteries.
Six patients who underwent coronary artery bypass surgery
and 3 patients who were hospitalized for heart failure in the
first 12 months of the study were excluded. Thus, a total of
217 patients with clinically stable CAD were ultimately
enrolled in this study. This study conformed to the 2005
version of the Ethical Guidelines for Clinical Study (Min-
istry of Health, Labour and Welfare of Japan), and was
approved by the ethics committees of the National Cardio-
vascular Center.
Magnetic resonance imaging. The MRI was performed
on a 1.5-T clinical system (Magnetom Sonata, Siemens,
Erlangen, Germany) with standard neck and spine array
coils. Plaque imaging was performed using MPRAGE in
transaxial sections using a null blood condition (effective
inversion time 660 ms; repetition time [TR] 1,500 ms) and
water excitation technique to suppress fat signals. The TR
was defined as the interval between successive inversion
pulses. Other imaging variables included echo time (TE)
5.0 ms; flip angle 15°; field of view 180  180 mm; matrix
56  204; slice thickness 1.25 mm; 56 partitions covering
0 mm around the carotid bifurcation; and data acquisition
ime 5 min. Multislab 3-dimensional time-of-flight mag-
etic resonance angiography (MRA) was also performed to
etermine lumen shape and plaque morphology with the
ollowing parameters: TE 4.4 ms; TR 35 ms; flip angle 15°.
he spatial resolution parameters were the same as with
PRAGE. Contrast MRA was performed after MPRAGE
nd 3-dimensional time-of-flight MRA. Gadolinium di-
thylenetriamine penta-acetic acid (Gd-DTPA, Magnevist,
ayer-Schering AG, Berlin, Germany), 0.1 mmol/kg body ceight, was infused at a rate of
.0 to 3.0 ml/s after a test bolus
f 1 ml Gd-DTPA. Contrast
RA imaging parameters in-
luded TR 3.2 ms; TE 1.3 ms;
lice thickness 1.0 mm; 64 parti-
ions; field-of-view 360  200
m; matrix 512  208; data
cquisition time 14 s; near-coronal
ection. Carotid stenosis was
easured using contrast MRA
ccording to the methods de-
ned by the NASCET (North
merican Symptomatic Carotid
ndarterectomy Trial) (15).
The methods used to evaluate
R images in this study have
een described previously (8).
riefly, an experienced radiologist
N.Y.) analyzed the carotid plaque
ignal intensity on MPRAGE rel-
tive to the adjacent muscle using
round region of interest (5 to 8
m in diameter). Figure 1 shows
epresentative cases with atherosclerotic plaques within the
arotid arteries. Criteria for the assessment of hyperintense
arotid plaques have been previously reported (8,16), and
atients with plaques in either the right or left carotid artery
n which any region of the plaque exhibited a signal
ntensity 200% of the adjacent muscle were placed in the
HIP group” (Fig. 1A). Otherwise, patients were placed in
he “non-HIP group” (Fig. 1D). The  values for interob-
server and intraobserver agreement for the categorization of
carotid plaques as HIP or non-HIP were 0.73 and 0.79,
respectively (8).
Ultrasound evaluation. A carotid ultrasound examination
was performed in the ultrasound laboratory using a 7.5-
MHz, linear-array transducer (SSA-270A, Toshiba, Tokyo,
Japan) shortly after admission but before MRI in all
patients. Two operators performed all carotid scans, and
they were unaware of the clinical characteristics of the
patients. The common carotid arteries were imaged bilat-
erally in the anterior oblique, lateral, and posterior oblique
planes to identify atherosclerotic lesions. On a longitudinal
image of each common carotid artery, intima media thick-
ness (IMT) was defined as the distance from the leading
edge of the lumen-intima interface to the leading edge of
the media-adventitia interface. The maximal IMT (IMTmax) was
efined as the thickest region of the far walls of either the
eft or right common carotid artery. All measurements were
erformed in a centralized laboratory by 2 trained physicians
ho were unaware of the subjects’ clinical data. The
nterreader variability defined by Spearman correlation co-
fficients on maximum wall thickness of the common
Abbreviations
and Acronyms
AMI  acute myocardial
infarction
CAD  coronary artery
disease
CI  confidence interval
HIP  high-intensity plaque
HR  hazard ratio
hsCRP  high-sensitivity
C-reactive protein
IMT  intima media
thickness
MPRAGE  magnetization-
prepared rapid acquisition
with gradient echo
MRA  magnetic
resonance angiography
MRI  magnetic resonance
imaging
TE  echo time
TR  repetition timearotid artery was 0.90.
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Carotid Plaques on MR Predict Coronary Events July 19, 2011:416–22Left ventricular function analysis. Left ventricular ejec-
tion fraction was measured by radioisotope image on single-
photon-emission computed tomography before MRI in all
patients.
Determination of serum C-reactive protein. High-sensitivity
C-reactive protein (hsCRP) was assayed by latex nephelom-
etry in fasting serum samples (SRL, Tokyo, Japan).
Follow-up study. After MRI data were obtained, the 217
patients with stable CAD were followed up at our hospital
for a period for 12 to 72 months or until the occurrence of
1 of the following clinical coronary events: cardiac death,
nonfatal AMI, unstable angina pectoris, or unplanned
hospitalization for recurrent angina. Percutaneous coronary
intervention-related restenosis was not considered a coro-
nary event. Chart review was conducted by independent
attending cardiologists to determine if subject hospitaliza-
tions and/or deaths qualified as primary endpoints of the
study. These chart reviewers were blinded to the patients’
HIP status. All stable CAD patients received standard
medical therapy, as outlined in Table 1.
Statistical analysis. Continuous baseline variables with
normal distribution were expressed as mean  SD and
ompared by unpaired t test. The Mann-Whitney U test
as used to evaluate differences in IMT, hsCRP, and
arotid artery stenosis. Categorical baseline variables were
ompared by Fisher exact test or chi-square analysis
here appropriate. Survival analysis was carried out using
he Kaplan-Meier method (log-rank test), according to
he presence or absence of HIP. The data were analyzed
Figure 1 Representative Plaque Images of Atherosclerotic Caro
In a patient with high-intensity plaques (HIP), (A) magnetization-prepared rapid acq
plaque of the right internal carotid artery (arrowheads); (B) time-of-flight magnetic
carotid arteries bilaterally (arrows); and (C) contrast MRA of the right carotid arte
tensity signals in the plaques of the internal carotid artery bilaterally, and the plaq
plays no significant luminal stenosis of the internal carotid arteries bilaterally (arronitially using a univariate model to determine the risk nfactors that had a significant association with future coro-
nary events. Multivariate Cox regression analysis was then
applied using only the covariates that significantly predicted
coronary events in the univariate analysis. All analyses were
conducted using SPSS (SPSS Japan Inc., Tokyo, Japan).
Results
Baseline clinical characteristics. The baseline clinical char-
acteristics of the study patients are shown in Table 1. The
median, first quartile, and third quartile range of carotid plaque
signal intensity relative to the adjacent muscle was 3.10, 2.67,
3.63, respectively, in the HIP group; and 1.51, 1.39, 1.70,
respectively, in the non-HIP group. The HIP group had
significantly higher levels of hsCRP and low-density lipopro-
tein cholesterol, higher rates of multivessel CAD and previous
MI, lower levels of high-density lipoprotein cholesterol, and
increased IMTmax values. There was no significant difference
n the degree of carotid artery stenosis between the 2 groups,
nd there were no differences in the administered medications
etween the 2 groups.
RI of carotid artery and prognostic value of HIP in
table CAD patients. One hundred sixteen of the 217
atients were categorized to the HIP group. Figure 1 shows
epresentative MR images of patients in the HIP group
Figs. 1A and 1B) and non-HIP group (Figs. 1D and 1E).
atients were followed up for a mean of 38.3 months. There
ere 31 coronary events in the HIP group during the
ollow-up period, but there were only 5 such events in the
rteries
n with gradient echo (MPRAGE) displays hyperintensity signals in the thick
ance angiography (MRA) displays no significant luminal stenosis of the internal
s no significant stenosis. In a patient lacking HIP, (D) MPRAGE displays isoin-
the left internal carotid artery is thick (arrowheads); (E) time-of-flight MRA dis-
nd (F) contrast MRA of the left carotid artery shows no significant stenosis.tid A
uisitio
reson
ry show
ue of
ws); aon-HIP group (n  101; p  0.001) (Table 2). When
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July 19, 2011:416–22 Carotid Plaques on MR Predict Coronary Eventsthese data were subjected to Kaplan-Meier analysis, the
presence of HIP was significantly associated with an in-
creased probability of coronary events in patients with stable
CAD (p  0.001 by log-rank test) (Fig. 2). Univariate
analysis of coronary risk factors, carotid ultrasound data, and
MRI analysis showed that IMTmax, HIP, multivessel CAD,
sCRP, and previous MI were all significant predictors of
linical coronary events (p  0.05) (Table 3). When these
actors were further analyzed by a multivariate Cox regres-
ion analysis, the presence of HIP was found to be the most
ignificant independent predictor of future coronary com-
lications in patients with stable CAD (hazard ratio [HR]:
.15, 95% confidence interval [CI]: 1.93 to 5.58, p 
.0001) compared with IMT (HR: 1.62, 95% CI: 0.97 to
.44, p  0.055) , hsCRP, previous MI, and multivessel
AD (Table 4). To further compare the presence of HIP to
MT, we used a cutoff value of 2.78 mm (i.e., the third
uartile of IMT in the present study) to define elevated
MT and performed an alternative multivariate Cox regres-
ion analysis. When this cutoff value was used, IMT was
ignificantly associated with cardiac events (HR: 1.79, 95%
I: 1.19 to 4.01, p  0.021), but the presence of carotid
IP (HR: 3.10, 95% CI: 1.79 to 5.01, p  0.0001)
emained the strongest indicator of future coronary events.
iscussion
e wished to identify a technique to allow for the better
Comparison of Baseline Clinical CharacteristicsTable 1 Comparison of Baseline Clinical Characteristics
HIP Group
(n  116)
Non-HIP Group
(n  101) p Value
Age, yrs 69 8 68 9 0.39
Male 90 (89%) 99 (85%) 0.41
Diabetes mellitus 35 (30%) 32 (32%) 0.81
Hypertension 79 (68%) 61 (60%) 0.24
Smoking 30 (26%) 30 (30%) 0.52
BMI, kg/m2 24.2 2.5 23.8 3.7 0.35
Total cholesterol, mg/dl 198 37 199 40 0.84
HDL cholesterol, mg/dl 43 11 48 16 0.007
LDL cholesterol, mg/dl 136 31 125 29 0.008
hsCRP, mg/dl 2.1 (1.0, 3.6) 1.35 (0.5, 2.3) 0.001
IMTmax, mm 2.17 1.1 1.67 1.0 0.001
Carotid artery stenosis, % 22.5 (15.0, 40.1) 20.5 (9.0, 40.9) 0.97
Medications
Aspirin 110 (95%) 98 (97%) 0.41
Beta-blocker 67 (58%) 62 (61%) 0.59
Statin 71 (61%) 64 (63%) 0.74
ACEI or ARB 50 (43%) 47 (47%) 0.61
Multivessel CAD 55 (55%) 31 (31%) 0.01
LV dysfunction (EF 40%) 8 (7%) 6 (6%) 0.77
Previous MI 42 (36%) 21 (21%) 0.01
Values are mean  SD, n (%), or median (first quartile, third quartile).
ACE  angiotensin-converting enzyme inhibitor; ARB  angiotensin II-receptor blocker; BMI 
ody mass index; CAD  coronary artery disease; EF  ejection fraction; HDL  high-density
lipoprotein; HIP  high-intensity plaques; hsCRP  high-sensitivity C-reactive protein; IMTmax 
aximum intima media thickness; LDL  low-density lipoprotein; LV  left ventricular; MI 
yocardial infarction.tratification of patients at risk of coronary events, and weypothesized that the nature of atherosclerotic plaques
hroughout the vasculature could be associated with coro-
ary plaque instability. As such, we used MPRAGE to
xamine the intensity of atherosclerotic plaques in the
arotid arteries and followed up patients with both high-
nd low-intensity plaques for the subsequent development
f coronary events. Our data suggest that the presence of
IP visualized by MPRAGE is a significant and indepen-
ent predictor of future coronary events in patients with
table CAD. Furthermore, the presence of HIP was a
tronger predictor of coronary events than increased carotid
rtery IMT. Thus, characterization of carotid plaques by
RI is clinically informative for risk stratification of pa-
ients with CAD.
Plaque instability and rupture were previously thought to
e isolated events at a specific site within the vasculature,
ut recent observations suggest that plaque destabilization is
characteristic of some patients that occurs at multiple sites
hroughout systemic vascular beds (17,18). Thus, the pres-
nce of vulnerable carotid plaques may reflect a systemic
roblem with plaques within the coronary vasculature
qually at risk to rupture and associated infarction. B-mode
ltrasound of the carotid arteries can identify plaques and
easure IMT, and both have been used as surrogate markers
or cardiovascular disease. Although IMT and the presence of
arotid plaques are highly related (19), the overall plaque area
as a stronger predictor of future coronary events than IMT
20). Additionally, carotid plaque characteristics, for exam-
le, echolucency, predicted coronary plaque complexity, and
he development of coronary complications in patients with
AD (2,21). While current data indicate that other radio-
ogic measures may be better than IMT for coronary risk
tratification, we elected to use IMT in this study because
MT is a more established technique, more widely available,
nd better validated in large populations (22).
In the present study, we used the MRI modality
PRAGE to characterize carotid plaques in patients with
table CAD. MPRAGE is a T1-weighted technique that
ighlights intraplaque components with short T1 signal
ith high signal intensity. It is thought that the lipid-rich
ecrotic cores of vulnerable plaques give rise to the observed
hort T1 signal (14,23–25). Alternatively, this may arise
rom intraplaque hemorrhage and thrombus formation
9,14,26,27). The presence of high-intensity signals sugges-
ive of complicated plaques was associated with subsequent
Summary of Coronary Events DuringFollow-Up Peri d in Patients With CADTable 2 Summ r of Corona y Events DuringFollow-Up Period in Patients With CAD
HIP Group
(n  116)
Non-HIP Group
(n  101) p Value
Composite endpoints 31 5 0.001
Cardiac death 4 0 0.125
Nonfatal acute MI 4 1 0.375
Unstable angina 16 2 0.002
Hospitalization for recurrent angina 7 2 0.180Abbreviations as in Table 1.
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Carotid Plaques on MR Predict Coronary Events July 19, 2011:416–22ischemic cerebrovascular events, and this was recognized as an
indicator of vulnerable carotid plaques (8,9). However, our
current data greatly expand the significance of carotid HIP by
showing that carotid HIP is a significant and independent
predictor of future coronary events in patients with stable
CAD. In fact, the presence of carotid HIP is a stronger
indicator of future coronary events than increased IMT.
Recent advances in technology have allowed for the devel-
opment of techniques that allow for the direct examination of
coronary artery plaque composition, for example, intravascular
ultrasound and angioscopy. However, these techniques are
invasive and are not practical for use in routine screening for
Univariate Analysis of Risk Factorsfor a Coronary Event in Patients With CADTable 3 Univariate Analysis f Risk Factorsfor a Coronary Event in Patients With CAD
Hazard
Ratio 95% CI p Value
Age, yrs 1.02 0.981.05 0.60
Male 1.71 0.723.32 0.29
Diabetes mellitus 1.68 0.884.41 0.15
Hypertension 0.89 0.471.61 0.71
Smoking 1.51 0.682.99 0.28
BMI, kg/m2 0.98 0.791.01 0.18
Total cholesterol, mg/dl 0.86 0.711.00 0.17
HDL cholesterol, mg/dl 0.95 0.981.05 0.21
LDL cholesterol, mg/dl 1.12 0.981.05 0.35
hsCRP, mg/dl 1.41 1.021.51 0.03
IMT, mm 1.55 1.121.89 0.004
Multivessel CAD 2.18 1.216.12 0.001
LV dysfunction (EF 40%) 1.70 0.812.33 0.11
Previous MI 1.95 1.195.35 0.001
Presence of HIP 1.76 1.213.32 0.001
Figure 2 Kaplan-Meier Curves Comparing Probability of a Coron
Kaplan-Meier curves comparing the probability of a coronary event occurring during
grouped according to the presence or absence of high-intensity plaques (HIP). The
cate confidence intervals. The solid red line indicates patients without HIP (n  1CI  confidence interval; other abbreviations as in Table 1.the management and risk assessment of patients with CAD.
Therefore, noninvasive imaging modalities capable of identi-
fying patients harboring unstable coronary lesions are needed.
Hence, the MRI-based evaluation of carotid plaques described
here provides clinically important information on the vulner-
ability of coronary atherosclerotic plaques to rupture and
correlates with future clinical outcome.
Inflammation plays important roles in atherogenesis and
plaque rupture (15,28–31). A common inflammatory path-
way linking carotid and coronary artery plaque activation
has been proposed based on the observed high C-reactive
protein levels seen in patients with CAD and echolucent
carotid plaques (32). In this study, the plasma levels of
hsCRP were significantly higher in the HIP group com-
pared with the non-HIP group, and increased levels of
hsCRP were independently associated with the presence of
HIP. Increased hsCRP levels are an independent predictor
of cardiovascular disease (33), and our results suggest that
the presence of both MPRAGE-detected HIP and elevated
hsCRP levels may indicate the presence of both vulnerable
and inflammatory activated plaques.
Multivariate Cox Regression Analysis ofRisk F ctors f r a Co onary EventTable 4 Multivariate Cox Regressi n Analysis ofRisk Factors for a Coronary Event
 SE
Hazard
Ratio p Value 95% CI
Presence of HIP 1.148 0.267 3.15 0.0001 1.935.58
IMT, mm 0.480 0.191 1.62 0.055 0.972.44
hsCRP 3.0 mg/dl 0.334 0.195 1.40 0.099 0.942.02
Previous MI 0.189 0.195 1.21 0.330 0.831.77
Multivessel CAD 0.240 0.201 1.27 0.219 0.861.90
vent
llow-up period of 72 months in 217 patients with stable coronary artery disease,
blue line indicates patients with HIP (n  116), and the dotted blue lines indi-
d the dotted red lines indicate confidence intervals.ary E
the fo
solid
01), anAbbreviations as in Tables 1 and 3.
fi
1

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small number of patients examined, and a few patients expe-
rienced a primary endpoint during the study. Hlatky et al. (34)
reported that a greater number of outcome events are needed to
provide adequate statistical power to fully evaluate whether a
novel risk marker contributes additional prognostic informa-
tion to an established set of risk factors in a multivariable model
rather than simply indicating whether the new marker is a
prognostic tool by itself. Therefore, while our data show that
the presence of HIP is a risk factor for coronary events, the
relative importance of HIP compared to other cardiac risk
factors should be evaluated and confirmed in a larger prospec-
tive study. We enrolled patients with stable CAD with50%
stenosis, and most acute coronary events occur with low-grade
or mild coronary stenosis. Additionally, we did not use a
multicontrast approach including 3 basic contrast weightings
(T1W, proton density, T2W). Use of these multicontrast
approaches in conjunction with time-of-flight MRA has been
shown to provide information regarding the thickness of the
fibrous cap, the lipid-rich necrotic core, and intraplaque hem-
orrhage (12,35–37). The combination of MPRAGE with
proton density and T2W techniques could further enhance
imaging based predictions of coronary plaque vulnerability.
The risks of nephrogenic systemic fibrosis were less
clearly understood during the study period in 2002 to 2005,
and we did not exclude patients with a glomerular filtration
rate 45 ml/min/1.73 m2. The overall mean glomerular
ltration rate of the study population was 78  19 ml/min/
.73 m2, and only 6 (2.7%) of the 217 patients had a GFR
45 ml/min/1.73 m2. None of these patients had nephro-
genic systemic fibrosis after administration of gadolinium.
Additionally, although we excluded 9 patients who had
cardiac events in the first year of follow-up, the inclusion of
these patients in the analyses did not affect the study results
(data not shown). Finally, the number of clinical events in
the study group was small, and follow-up was limited to 3
years. A more substantial, longer-term study with more
patients is needed to clarify the short- and long-term
prognostic roles of MRI as well as the role of MRI screening
for high-risk asymptomatic patients.
Conclusions
The presence of HIP detected by MPRAGE in the carotid
arteries predicts the development of future coronary complica-
tions in patients with stable CAD. Noninvasive evaluation of
carotid plaques using MRI with MPRAGE is clinically infor-
mative in the risk stratification of CAD patients.
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